FDA Drug Safety Approach To Be Questioned At House Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Principal Deputy Commissioner Joshua Sharfstein is scheduled to go before the House Energy and Commerce Health Subcommittee on March 10.